Connection
Jennifer Diamond to Vascular Endothelial Growth Factor Receptor-2
This is a "connection" page, showing publications Jennifer Diamond has written about Vascular Endothelial Growth Factor Receptor-2.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.089 |
|
|
|
-
Diamond JR, Bastos BR, Hansen RJ, Gustafson DL, Eckhardt SG, Kwak EL, Pandya SS, Fletcher GC, Pitts TM, Kulikowski GN, Morrow M, Arnott J, Bray MR, Sidor C, Messersmith W, Shapiro GI. Phase I safety, pharmacokinetic, and pharmacodynamic study of ENMD-2076, a novel angiogenic and Aurora kinase inhibitor, in patients with advanced solid tumors. Clin Cancer Res. 2011 Feb 15; 17(4):849-60.
Score: 0.089